Health score, price, valuation, risk signals, and key metrics at a glance.
Strongest: Growth (10/25); weakest: Profitability (7/25).
Today's multiple positioned against its own trailing range — a visual premium/discount check.
Currently above its 5-quarter median.
Data-driven signals worth keeping an eye on across the last 8 quarters
The company posted negative operating margins in recent quarters — core operations are unprofitable.
FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.
as of June 2026
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
D/E ratio is 3.8 — heavily leveraged and vulnerable to rising rates or cash flow dips.
FCF turned negative in 2 of the last 5 quarters — occasional cash consumption.
Shares outstanding increased 295062757.0% — significant dilution, likely from stock compensation or capital raises.
